Compartir
Drug Safety: Managing Innovation in Rheumatology, an Issue of Rheumatic Disease Clinics: Volume 38-4
John J. Cush
(Autor)
·
Kathryn H. DAO
(Autor)
·
Saunders
· Tapa Dura
Drug Safety: Managing Innovation in Rheumatology, an Issue of Rheumatic Disease Clinics: Volume 38-4 - Cush, John J. ; DAO, Kathryn H.
Sin Stock
Te enviaremos un correo cuando el libro vuelva a estar disponible
Reseña del libro "Drug Safety: Managing Innovation in Rheumatology, an Issue of Rheumatic Disease Clinics: Volume 38-4"
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.